The Science Behind Hedonia:
Nourishing Your Brain Naturally
Understanding the Missing Link: Nutritional Deficiencies in Depression
Recent research has uncovered a crucial link between depression and specific nutritional deficiencies. People with depression often have unique nutritional imbalances that:
• Differ from those in the general population
• Cannot be corrected by diet alone
• May impact the effectiveness of antidepressant medications
As a medical food, Hedonia is specifically formulated to address these deficiencies. Unlike ordinary dietary supplements, medical foods:
• Are formulated based on recognized scientific principles
• Address distinct nutritional requirements associated with a specific medical condition or disease. In this case Depression.
The Brain’s Nutritional Needs
Hedonia’s patented 3-in-1 formula is the result of decades of research in nutritional psychiatry, offering a targeted approach to supporting brain health in people with depression.
Imagine your brain as a complex machine, like a car. Antidepressants act as engine fuel, but for optimal function, the brain also needs specific “maintenance nutrients”.
These nutrients are essential for producing and regulating neurotransmitters – the chemicals that affect mood. Studies have revealed that people with depression often lack key nutrients like folate, omega-3 fatty acids, and other crucial nutrients for healthy brain function. Without these nutrients , the brain’s ability to produce and regulate neurotransmitters is impaired.
How Nutritional Deficiencies Affect Treatment
Antidepressants work by influencing neurotransmitters in your brain. However, if the brain lacks the raw materials (nutrients) to produce these neurotransmitters, the medication can’t function at its full potential. It’s akin to a car running on fuel but missing essential components for smooth operation.
Hedonia’s Role in Optimizing Treatment
Hedonia is specifically formulated to address the nutritional deficiencies linked to depression. It provides 3 key nutrients; L-Methylfolate, S-Adenosyl methionine (SAM-e) and Omega-3 fatty acids (EPA) that your brain needs to produce and regulate neurotransmitters. By supplying these ‘missing ingredients’, Hedonia helps create an environment where your antidepressants can work more effectively.
Remember, Hedonia isn’t a replacement for prescribed medication, but a complementary approach designed to address a critical, often overlooked aspect of depression – your brain’s nutritional needs.
By targeting these research-identified deficiencies, Hedonia aims to optimize the environment for antidepressant efficacy, leading to better outcomes in the management of depression.
Articles
Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce. The World Journal of Biological Psychiatry, 23(6), 424–455.
Sarris, J., Ravindran, A., Yatham, L. N., Marx, W., Rucklidge, J. J., McIntyre, R. S., … Berk, M. (2022).
Diet and Depression: Exploring the Biological Mechanisms of Action. Molecular Psychiatry, 2021.
Marx W, Lane M, Hockey M…, Firth J, et al. (2020)
Food and mood: how do diet and nutrition affect mental wellbeing?. The BMJ ; 2020 Jun 29;369.
Firth J, Gangwisch JE, Borsini A, Wootton RE, Mayer EA
EPA and DHA as markers of nutraceutical treatment response in major depressive disorder. European journal of nutrition, 59, 2439-2447.
van der Burg, K. P., Cribb, L., Firth, J., Karmacoska, D., Mischoulon, D., Byrne, G. J., … & Sarris, J. (2020)
The efficacy and safety of nutrient supplements in the treatment of mental disorders: a meta‐review of meta‐analyses of randomized controlled trials. World Psychiatry, 18(3), 308-324.
Firth, J., Teasdale, S. B., Allott, K., Siskind, D., Marx, W., Cotter, J., … & Sarris, J. (2019)
International Society for Nutritional Psychiatry Research Practice Guidelines for Omega-3 Fatty Acids in the Treatment of Major Depressive Disorder. Psychother Psychosom. 2019;88(5):263-273. doi: 10.1159/000502652. Epub 2019 Sep 3. PMID: 31480057.
Guu TW, Mischoulon D, Sarris J, Hibbeln J, McNamara RK, Hamazaki K, Freeman MP, Maes M, Matsuoka YJ, Belmaker RH, Jacka F, Pariante C, Berk M, Marx W, Su KP
Nutrient and genetic biomarkers of nutraceutical treatment response in mood and psychotic disorders: a systematic review. Nutritional neuroscience. 2021 Apr 3;24(4):279-95.
Van Der Burg KP, Cribb L, Firth J, Karmacoska D, Sarris J
What is the role of dietary inflammation in severe mental illness? A review of observational and experimental findings. Frontiers in psychiatry. 2019 May 15;10:443755.
Firth J, Veronese N, Cotter J, Shivappa N, Hebert JR, Ee C, Smith L, Stubbs B, Sarris J
The effects of dietary improvement on symptoms of depression and anxiety: a meta-analysis of randomized controlled trials. Psychosomatic medicine, 81(3), pp.265-280.
Firth, J., Marx, W., Dash, S., Carney, R., Teasdale, S.B., Solmi, M., Stubbs, B., Schuch, F.B., Carvalho, A.F., Jacka, F. and Sarris, J., 2019
The Vitamins in Psychosis Study: A randomised, double-blind, placebo-controlled trial of the effects of vitamin B12, B6 and folic acid on symptoms and neurocognition in first-episode psychosis. Biological Psychiatry, doi: 10.1016/j.biopsych.2018.12.018
Allot K, McGorry P, Yuen HP, Firth J, et al. (2019)
Diet as a hot topic in psychiatry: a population‐scale study of nutritional intake and inflammatory potential in severe mental illness. World Psychiatry. 2018 Oct;17(3):365.
Firth J, Stubbs B, Teasdale SB, Ward PB, Veronese N, Shivappa N, Hebert JR, Berk M, Yung AR, Sarris J
The relationship between the dietary inflammatory index and incident depressive symptoms: a longitudinal cohort study. Journal of Affective Disorders, 235: 39-44
Shivappa N, Hébert J, Veronese N, …, Firth J, et al. (2018)
Adjunctive nutrients in first‐episode psychosis: a systematic review of efficacy, tolerability and neurobiological mechanisms. Early intervention in psychiatry. 2018 Oct;12(5):774-83.
Firth J, Rosenbaum S, Ward PB, Curtis J, Teasdale SB, Yung AR, Sarris J
Diet as a hot topic in psychiatry: a population-scale study of nutritional intake and inflammatory potential in severe mental illness. World Psychiatry, 17 (3), 365-367.
Firth J, Stubbs B, Teasdale S, …, Sarris J. (2018)
Nutritional deficiencies and clinical correlates in first-episode psychosis: a systematic review and meta-analysis. Schizophrenia bulletin. 2018 Oct 17;44(6):1275-92.
Firth J, Carney R, Stubbs B, Teasdale SB, Vancampfort D, Ward PB, Berk M, Sarris J
The effects of vitamin and mineral supplementation on symptoms of schizophrenia: a systematic review and meta-analysis. Psychological medicine. 2017 Jul;47(9):1515-27.
Firth J, Stubbs B, Sarris J, Rosenbaum S, Teasdale S, Berk M, Yung AR
Polyunsaturated fatty acids and suicide risk in mood disorders: A systematic review. Progress in Neuropsychopharmacology & Biological Psychiatry 2016.
Maurizio Pompili, Lucia Longo, Giovanni Dominici, Gianluca Serafini, Dorian A. Lamis, Jerome Sarris, Mario Amore, Paolo Girardi
Adjunctive Nutraceuticals for Depression: A Systematic Review and Meta Analyses. Am J Psychiatry 2016, 00(1-13).
J. Sarris, J. Murphy, D. Mischoulon, G. I. Papakostas, M. Fava, M. Berk, C. H. Ng
Is S-Adenosyl Methionine (SAMe) for Depression Only Effective in Males? A Re-Analysis of Data from a Randomized Clinical Trial. Pharmacopsychiatry 2015; 48(04/05): 141-144.
J. Sarris, L. H. Price, L. L. Carpenter, A. R. Tyrka, C. H. Ng, G. I. Papakostas, A. Jaeger, M. Fava, D. Mischoulon
Nutritional medicine as mainstream in psychiatry. Personal View, 2(3): 271-274.
J. Sarris, A. C. Logan, T. N. Akbaraly, G. P. Amminger, V. Balanzá-Martínez, M. P. Freeman, et al (2015)